Copertina

Generalizing the intention-to-treat effect of an active control against placebo from historical placebo-controlled trials to an active-controlled trial: A case study of the efficacy of daily oral TDF/FTC in the HPTN 084 study

Fuente: arXiv

Salvato in:

Dettagli Bibliografici
Autori principali:	He, Qijia, Gao, Fei, Dukes, Oliver, Delany-Moretlwe, Sinead, Zhang, Bo
Natura:	Preprint
Pubblicazione:	2023
Soggetti:	Methodology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

A comparison of methods for estimating the average treatment effect on the treated for externally controlled trials
di: Wang, Huan, et al.
Pubblicazione: (2024)

On estimands in target trial emulation
di: Gervasoni, Edoardo Efrem, et al.
Pubblicazione: (2026)

Dealing with positivity violations in mediation analysis via weighted controlled effects, with application to assessing immune correlates of protection in antigen-experienced participants
di: He, Qijia, et al.
Pubblicazione: (2026)

Evaluating hybrid controls methodology in early-phase oncology trials: a simulation study based on the MORPHEUS-UC trial
di: Wang, Guanbo, et al.
Pubblicazione: (2022)

Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
di: Zhao, Pan, et al.
Pubblicazione: (2026)

Treatment-control comparisons in platform trials including non-concurrent controls
di: Roig, Marta Bofill, et al.
Pubblicazione: (2024)

Evaluating the performance of Bayesian cumulative logistic models in randomised controlled trials: a simulation study
di: Selman, Chris J., et al.
Pubblicazione: (2025)

Improving precision of cumulative incidence estimates in randomized controlled trials with external controls
di: Su, Zehao, et al.
Pubblicazione: (2025)

Robust integration of external control data in randomized trials
di: Karlsson, Rickard, et al.
Pubblicazione: (2024)

Causal progress with imperfect placebo treatments and outcomes
di: Rohde, Adam, et al.
Pubblicazione: (2023)

A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
di: Jeffrey D. Sharon, et al.
Pubblicazione: (2024)

Using causal diagrams to assess parallel trends in difference-in-differences studies
di: Renson, Audrey, et al.
Pubblicazione: (2025)

Ethical considerations on placebo-controlled vaccine trials in pregnant women
di: Ana Cecilia Amado Xavier de Oliveira
Pubblicazione: (2023)

Data-driven controlled subgroup selection in clinical trials
di: Müller, Manuel M., et al.
Pubblicazione: (2025)

On the inclusion of non-concurrent controls in platform trials with an interim analysis
di: Krotka, Pavla, et al.
Pubblicazione: (2025)

ADDIS-Graphs for online error control with application to platform trials
di: Fischer, Lasse, et al.
Pubblicazione: (2023)

Blinded sample size recalculation in randomized controlled trials with analysis of covariance
di: Kanata, Takumi, et al.
Pubblicazione: (2025)

Family-wise error rate control in clinical trials with overlapping populations
di: Luschei, Remi, et al.
Pubblicazione: (2025)

A Bayesian likely responder approach for the analysis of randomized controlled trials
di: Deng, Annan, et al.
Pubblicazione: (2025)

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
di: Nathaniel M. Schuster, et al.
Pubblicazione: (2025)

Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial
di: Luiz Antonio Bastos Camacho
Pubblicazione: (2005)

Evaluating the effect of different non-informative prior specifications on the Bayesian proportional odds model in randomised controlled trials: a simulation study
di: Selman, Chris J., et al.
Pubblicazione: (2025)

Leveraging external data in the analysis of randomized controlled trials: a comparative analysis
di: Kotecha, Gopal, et al.
Pubblicazione: (2024)

Improving randomized controlled trial analysis via data-adaptive borrowing
di: Gao, Chenyin, et al.
Pubblicazione: (2023)

Estimating treatment effects with competing intercurrent events in randomized controlled trials
di: Lu, Sizhu, et al.
Pubblicazione: (2025)

Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
di: Emmanuelle A. D. Schindler, et al.
Pubblicazione: (2025)

On the estimation of inclusion probabilities for weighted analyses of nested case control studies
di: López-Nieto-Veitch, Tomeu, et al.
Pubblicazione: (2026)

Making all pairwise comparisons in multi-arm clinical trials without control treatment
di: Burnett, Thomas, et al.
Pubblicazione: (2024)

Jointly modeling multiple endpoints for efficient treatment effect estimation in randomized controlled trials
di: Wolf, Jack M., et al.
Pubblicazione: (2025)

On the uncertainty from the first-stage estimation of prognostic covariate adjustment in randomized controlled trials
di: Seya, Nodoka, et al.
Pubblicazione: (2026)

NCC: An R-package for analysis and simulation of platform trials with non-concurrent controls
di: Krotka, Pavla, et al.
Pubblicazione: (2023)

Increasing power and robustness in screening trials by testing stored specimens in the control arm
di: Katki, Hormuzd A., et al.
Pubblicazione: (2024)

Doubly robust omnibus sensitivity analysis of externally controlled trials with intercurrent events
di: Gao, Chenyin, et al.
Pubblicazione: (2025)

Comparative efficacy and tolerability of currently approved incretin mimetics: A systematic analysis of placebo‐controlled clinical trials
di: Yu Mi Kang, et al.
Pubblicazione: (2025)

Dynamic borrowing from historical controls via the synthetic prior with covariates in randomized clinical trials
di: Schwartz, Daniel E., et al.
Pubblicazione: (2024)

Statistical modeling to adjust for time trends in adaptive platform trials utilizing non-concurrent controls
di: Krotka, Pavla, et al.
Pubblicazione: (2024)

Doubly protected estimation for survival outcomes utilizing external controls for randomized clinical trials
di: Gao, Chenyin, et al.
Pubblicazione: (2024)

Trick or treat? It's time to rethink the role of placebo in clinical trial
di: Ping‐Tao Tseng, et al.
Pubblicazione: (2024)

A likelihood approach to proper analysis of secondary outcomes in matched case-control studies
di: Liu, Shanshan, et al.
Pubblicazione: (2026)

Identification and estimation of causal effects using non-concurrent controls in platform trials
di: Santacatterina, Michele, et al.
Pubblicazione: (2024)